IP Verse

Tablets Comprising Eltrombopag Olamine - EP4218732

EP4218732

NOVARTIS
Application Number
EP23166852A
Filing Date
Aug 1, 2007
Status
Granted And Under Opposition
Feb 21, 2025
Grant Date
Mar 26, 2025
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3143995B2
EP3397755B1
EP4321157B1

Bibliography

The patent EP4218732B1 was granted to Novartis on Mar 26, 2025 following the initial filing on Aug 1, 2007 under the application number EP23166852A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STADA ARZNEIMITTELAug 5, 2025 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents